X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9156) 9156
Book Review (1646) 1646
Publication (497) 497
Book Chapter (42) 42
Conference Proceeding (19) 19
Newspaper Article (5) 5
Book / eBook (4) 4
Magazine Article (3) 3
Trade Publication Article (2) 2
Journal / eJournal (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8367) 8367
humans (8305) 8305
male (6061) 6061
female (5645) 5645
middle aged (5322) 5322
aged (4569) 4569
salvage therapy (3974) 3974
adult (3920) 3920
treatment outcome (3839) 3839
oncology (3289) 3289
surgery (2997) 2997
retrospective studies (2873) 2873
aged, 80 and over (1988) 1988
cancer (1931) 1931
chemotherapy (1792) 1792
survival rate (1770) 1770
prognosis (1670) 1670
hematology (1566) 1566
disease-free survival (1545) 1545
antineoplastic combined chemotherapy protocols - therapeutic use (1542) 1542
follow-up studies (1500) 1500
care and treatment (1496) 1496
radiotherapy (1468) 1468
salvage therapy - methods (1446) 1446
time factors (1400) 1400
risk factors (1367) 1367
survival analysis (1345) 1345
adolescent (1312) 1312
limb salvage (1301) 1301
combined modality therapy (1237) 1237
salvage (1212) 1212
recurrence (1206) 1206
survival (1169) 1169
therapy (1058) 1058
neoplasm staging (1039) 1039
peripheral vascular disease (1007) 1007
kaplan-meier estimate (972) 972
abridged index medicus (938) 938
medicine & public health (934) 934
analysis (914) 914
transplantation (901) 901
amputation (852) 852
young adult (823) 823
health aspects (813) 813
neoplasm recurrence, local - mortality (790) 790
management (785) 785
mortality (774) 774
radiation-therapy (731) 731
patients (693) 693
child (650) 650
research (644) 644
relapse (634) 634
prospective studies (617) 617
trial (615) 615
hematology, oncology and palliative medicine (612) 612
remission induction (608) 608
radiology, nuclear medicine & medical imaging (601) 601
proportional hazards models (571) 571
risk assessment (565) 565
neoplasm recurrence, local - surgery (564) 564
carcinoma (550) 550
neoplasm recurrence, local - pathology (541) 541
prostate cancer (538) 538
multivariate analysis (528) 528
patient outcomes (525) 525
ischemia (519) 519
disease (516) 516
vascular patency (514) 514
antineoplastic combined chemotherapy protocols - adverse effects (503) 503
outcomes (494) 494
urology & nephrology (492) 492
treatment failure (482) 482
transplantation, autologous (477) 477
cardiac & cardiovascular systems (475) 475
antineoplastic agents - therapeutic use (466) 466
antineoplastic combined chemotherapy protocols - administration & dosage (461) 461
immunology (451) 451
carcinoma, squamous cell - mortality (431) 431
experience (431) 431
radiation (431) 431
reoperation (424) 424
hematopoietic stem cell transplantation (422) 422
risk (415) 415
tumors (409) 409
lower extremity - blood supply (403) 403
metastasis (399) 399
angioplasty (398) 398
ischemia - surgery (398) 398
squamous-cell carcinoma (398) 398
radiation therapy (394) 394
stem cells (394) 394
diseases (388) 388
phase-ii (388) 388
child, preschool (387) 387
cisplatin (384) 384
ischemia - therapy (384) 384
neoplasm recurrence, local - drug therapy (382) 382
otorhinolaryngology (378) 378
disease progression (376) 376
neoplasm recurrence, local (375) 375
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8970) 8970
German (74) 74
French (40) 40
Spanish (33) 33
Japanese (28) 28
Chinese (19) 19
Italian (9) 9
Korean (9) 9
Russian (7) 7
Hungarian (5) 5
Polish (5) 5
Portuguese (4) 4
Czech (3) 3
Swedish (3) 3
Turkish (3) 3
Bulgarian (1) 1
Danish (1) 1
Dutch (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 293 - 300
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 67, Issue 2, pp. 299 - 309
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 6, pp. 886 - 893
Journal Article
Blood, ISSN 0006-4971, 11/2016, Volume 128, Issue 18, pp. 2199 - 2205
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 97, Issue 5, pp. 962 - 975
Purpose We compare the efficacy and toxicity among the 3 major modalities available used to treat high-risk prostate cancer (HRCaP). Methods and Materials From... 
Radiology | Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | ONCOLOGY | ADENOCARCINOMA | CONSENSUS CONFERENCE | BIOCHEMICAL FAILURE | RANDOMIZED-TRIAL | INTERMEDIATE | RADIOTHERAPY | SUPPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | HORMONAL-THERAPY | NEOADJUVANT | Radiation Injuries - mortality | Humans | Middle Aged | Chemoradiotherapy - mortality | Male | Salvage Therapy - utilization | Prostatic Neoplasms - therapy | Radiotherapy, Adjuvant - mortality | Aged, 80 and over | Adult | Retrospective Studies | Ohio - epidemiology | Chemoradiotherapy - utilization | Radiotherapy, Conformal - utilization | Salvage Therapy - mortality | Brachytherapy - mortality | Gastrointestinal Diseases - mortality | Gastrointestinal Diseases - prevention & control | Survival Rate | Treatment Outcome | Prostatic Neoplasms - mortality | Disease-Free Survival | Radiation Injuries - prevention & control | Radiotherapy, Conformal - mortality | Prostatectomy - utilization | Aged | Brachytherapy - utilization | Androgen Antagonists - administration & dosage | Prostatectomy - mortality | Radiotherapy, Adjuvant - utilization | Longitudinal Studies | Continuing medical education | Care and treatment | Radioisotope brachytherapy | Surgery | Adjuvant treatment | Health aspects | Prostate cancer | Risk factors | Cancer | Mortality | Index Medicus | PROSTATE | EXTERNAL BEAM RADIATION THERAPY | NEOPLASMS | RADIATION HAZARDS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | TOXICITY | ANDROGENS | BRACHYTHERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 91, Issue 3, pp. 480 - 488
Purpose Salvage options for unresectable locally recurrent, previously irradiated squamous cell carcinoma of the head and neck (rSCCHN) are limited. Although... 
Radiology | Hematology, Oncology and Palliative Medicine | SURVIVAL | CAROTID BLOWOUT SYNDROME | LOCALLY-RECURRENT | PROGNOSTIC-FACTORS | FEASIBILITY | CISPLATIN | ONCOLOGY | CANCER-DISEASE-CONTROL | CONCURRENT CHEMOTHERAPY | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | TUMOR VOLUME | Neoplasm Recurrence, Local - radiotherapy | Prospective Studies | Neoplasms, Squamous Cell - surgery | Retreatment - mortality | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Squamous Cell - radiotherapy | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Carcinoma, Squamous Cell - mortality | Time Factors | Neoplasms, Squamous Cell - radiotherapy | Aged, 80 and over | Female | Cetuximab | Radiosurgery - methods | Radiotherapy Planning, Computer-Assisted | Salvage Therapy - mortality | Radiotherapy Dosage | Neoplasms, Squamous Cell - mortality | Antibodies, Monoclonal, Humanized - therapeutic use | Quality of Life | Aged | Retreatment - methods | Salvage Therapy - methods | Antimitotic agents | Squamous cell carcinoma | Care and treatment | Relapse | Chemotherapy | Radiation | Clinical trials | Radiotherapy | Antineoplastic agents | Diseases | Cancer | Index Medicus | KIDNEYS | HEAD | IRRADIATION | PATIENTS | LIVER | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | TOXICITY | NECK | COMPARATIVE EVALUATIONS | CHEMOTHERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. 101 - 108
Purpose To assess the survival benefit of early vs late salvage hormonal therapy (HT), we performed a secondary analysis on patients who developed recurrence... 
Radiology | Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | ANDROGEN DEPRIVATION | RELAPSE | ONCOLOGY | DEFINITIVE RADIOTHERAPY | RANDOMIZED-TRIAL | ABLATION | RECURRENCE | SUPPRESSION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ANTIGEN | Neoplasm Recurrence, Local - radiotherapy | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Time Factors | Antineoplastic Agents, Hormonal - therapeutic use | Prostatic Neoplasms - blood | Neoplasm Recurrence, Local - blood | Prostatic Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Salvage Therapy - mortality | Prostatic Neoplasms - pathology | Drug Administration Schedule | Adenocarcinoma - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Analysis of Variance | Neoadjuvant Therapy - methods | Survival Analysis | Aged | Salvage Therapy - methods | Adenocarcinoma - mortality | Medical research | Cancer patients | Care and treatment | Nuclear radiation | Patient outcomes | Adjuvant treatment | Medicine, Experimental | Radiotherapy | Prostate cancer | Cancer | Index Medicus | PROSTATE | MULTIVARIATE ANALYSIS | PATIENTS | HEALTH HAZARDS | FAILURES | METASTASES | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | ANTIGENS | RADIOTHERAPY | HORMONES
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 62, Issue 3, pp. 472 - 487
Journal Article